Physician profile
Elena Reece
NPI 1619086667
$5,407.21
in general payments reported to CMS, 2019-2025
21 companies · $861 in 2025
The $861 reported for 2025 was more than what a typical Pediatric Allergy/Immunology provider received nationally (typical 2025 total: $375).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $854 · 2020: $375 · 2021: $1,002 · 2022: $1,080 · 2023: $716 · 2024: $520 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,096.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,144.68 | 2019-2025 | Nucala, Benlysta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,011.73 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Novartis Pharmaceuticals Corporation | $621.28 | 2019-2025 | |
| Amgen INC. | $582.53 | 2019-2023 | Enbrel, Otezla, Tezspire |
| Genzyme Corporation | $431.43 | 2019-2025 | |
| Csl Behring | $374.35 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $284.23 | 2019-2025 | Dupixent |
| Ucb, INC. | $241.22 | 2019-2025 | Cimzia, Bimzelx |
| Janssen Biotech, INC. | $170.01 | 2020-2025 | Darzalex, Talvey, Tremfya |
| Phadia US INC. | $125.39 | 2021-2024 | Immunocap |
| Genentech USA, INC. | $76.84 | 2021-2024 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $76.82 | 2022-2023 | Takhzyro |
| Leo Pharma INC. | $60.04 | 2022 | |
| Grifols USA, LLC | $45.49 | 2022 | |
| Aurinia Pharma U.S., INC. | $45.05 | 2021-2023 | Lupkynis |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $27.44 | 2023 | Strensiq |
| Mallinckrodt Hospital Products INC. | $24.97 | 2022 | |
| Optinose US, INC. | $18.28 | 2020 | |
| Sobi, INC | $17.31 | 2019 | |
| Circassia INC. | $16.02 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Reece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.